Market revenue in 2023 | USD 35.3 million |
Market revenue in 2030 | USD 72.4 million |
Growth rate | 10.8% (CAGR from 2023 to 2030) |
Largest segment | Ferric carboxymaltose |
Fastest growing segment | Iron Sucrose |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Iron Dextran, Iron Sucrose, Ferric Carboxymaltose |
Key market players worldwide | AbbVie Inc, Civitas Resources Inc Ordinary Shares, Daiichi Sankyo Co Ltd, Sanofi SA, CSL Ltd, COSMOS Pharmaceutical Corp, Zydus Lifesciences, Rockwell Medical Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous iron drugs market will help companies and investors design strategic landscapes.
Ferric carboxymaltose was the largest segment with a revenue share of 50.42% in 2023. Horizon Databook has segmented the India intravenous iron drugs market based on iron dextran, iron sucrose, ferric carboxymaltose covering the revenue growth of each sub-segment from 2018 to 2030.
The National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) is funded by the National Health Mission (NHM) to enhance awareness about the treatment and diagnosis of these diseases. Some of the most commonly occurring cancers in India are cervical, breast, and oral cancer.
The costs of diagnosis and treatment of cancer are high; about threequarters of cancer-related expenditure is paid out of pocket despite the availability of various cancer treatment welfare schemes. Therefore, states are encouraged to leverage existing schemes under the NHM, as well as state-level health protection schemes, to reduce the financial burden on individuals.
The population of the country has displayed rapid changes in dietary practices, socioeconomic milieu, and lifestyle. Detection and diagnostic technologies have been consistently improving, and a majority of the population can currently access & afford these technologies.
Horizon Databook provides a detailed overview of country-level data and insights on the India intravenous iron drugs market , including forecasts for subscribers. This country databook contains high-level insights into India intravenous iron drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account